InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,938.73
(
0.08%
)
Post# of 14
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ECole

Send PM Follow Ignore
Followers 21
Posts 1331
Boards Moderated 1
Alias Born 07/02/2013

ECole

Re: None

Monday, 08/26/2013 7:16:32 AM

Monday, August 26, 2013 7:16:32 AM

Post# of 14
Peregrine Pharma at Wedbush-2013-Life-Sciences-Management-Access-Conference

Have two Phase III ready clinical programs bavituximab which is their lead program, and Cotara program. They have FDA agreements for both of those compounds for Phase III trial designs.

http://www.earningsimpact.com/Transcript/82836/PPHM/Peregrine-Pharmaceuticals---Wedbush-2013-Life-Sciences-Management-Access-Conference
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up